Theralase Technologies Inc. V.TLT

An Update on Key Areas of Progress In Bladder Cancer

[ScienceFirst]

We should hear about him.  Our MASB Dr. Kamat.

Last year (August 2022), we hadn't reached the minimum threshold of 25 patients @450-days.  This year, we should start being in the conversations and in papers.like this one:

Ashish Kamat, MD, MBBS, is a Professor of Urology and Cancer Research and Wayne B. Duddleston Professor of Cancer Research at MD Anderson Cancer Center in Houston, Texas. Dr. Kamat serves as President of International Bladder Cancer Group, (IBCG), and Co-President of International Bladder Cancer Network.

The Latest Research on Bladder Cancer - UroToday

An Update on Key Areas of Progress In Bladder Cancer

Ashish M. Kamat | August 15, 2022

Urothelial carcinoma remains one of the most common malignancies, with about 81,000 new diagnoses and approximately 17,000 associated deaths in 2022 alone.1 Survival numbers are dependent on early diagnosis and drop with delayed diagnosis and/or advanced stages of disease.1 Both muscle-invasive bladder cancer (MIBC) and non-muscle invasive bladder cancer (NMIBC) are associated with substantial morbidity and reduced quality of life.

READ MORE PREVIOUS ARTICLES

 

[Infinity]

I did not see a passing mention about the TLD or any PDT treatments any where in this article from someone who is very knowledgeable about the progress so far.  https://www.urotoday.com/center-of-excellence/bladder-cancer/from-the-editor/138877-bladder-cancer-center-of-excellence-update-on-key-areas-of-progress.html

[Rumpl3StiltSkin]

I think this just indicates how far TLT, and their ACT for NMIBC, is still under the radar. Interesting thing in this article is that they define the population of patients as 'intending to treat' . Brings up the question of how large the late stage market for this life/bladder saving tech really is?? How large is the population of late stage patients that are just going to let it go

[CAinPlap]

I find lack of mention of us as concerning/insulting. Is it because they haven't heard of us or is it that they ar not as enthusiastic about our potential as we are?

[Rumpl3StiltSkin]

I think it is just that PDT is so outta mainstream. It shouldn't be much longer though.

[NotinKansas]

We are mentioned, somewhere halfway, in the paragraph starting with "Many other studies ..." "intravesical photodynamic therapy (phase 2; NCT03945162)", that's us.